| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.9 |